drugset / Trial / NCT00532415

Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy

NCT00532415

Phase 3 Completed 60 enrolled Alcon Research
NaSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of triamcinolone acetonide suspension when used for visualization of structures in the back of the eye during eye surgery.

Timeline

Start
2007-09
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified

Indications

No indication recorded.